Gambling on putative biomarkers of osteoarthritis and osteochondrosis by equine synovial fluid proteomics

Journal of Proteomics

Volumn 75, Issue 14, 2012, Pages 4478-4493

  Chiaradia, Elisabetta ^a   Pepe, Marco ^a   Tartaglia, Micaela ^a   Scoppetta, Fausto ^a   D'Ambrosio, Chiara ^b   Renzone, Giovanni ^b   Avellini, Luca ^a   Moriconi, Franco ^a   Gaiti, Alberto ^a   Bertuglia, Andrea ^c   Beccati, Francesca ^a   Scaloni, Andrea ^b  

^a UNIVERSITY OF PERUGIA   (Italy)

^b CNR   (Italy)

^c UNIVERSITY OF TURIN   (Italy)

Author keywords

Horse; Osteoarthritis; Osteochondrosis; Proteomics; Synovial fluid

Indexed keywords

ALBUMIN; ALPHA 2 MACROGLOBULIN; ALTERNATIVE COMPLEMENT PATHWAY C3 C5 CONVERTASE; ANTITHROMBIN III; APOLIPOPROTEIN A1; CARBOXYLESTERASE; CARBOXYLESTERASE D1; CERULOPLASMIN; COMPLEMENT COMPONENT C4A; FIBRINOGEN; HAPTOGLOBIN; INTERLEUKIN 1 RECEPTOR BLOCKING AGENT; PLASMINOGEN; PLATELET DERIVED GROWTH FACTOR; PREALBUMIN; SOMATOMEDIN C; TRANSFERRIN; TRANSFORMING GROWTH FACTOR BETA; UNCLASSIFIED DRUG;

ANIMAL EXPERIMENT; ANIMAL TISSUE; ARTICLE; BLOOD VESSEL PERMEABILITY; CONTROLLED STUDY; FEMALE; HOMEOSTASIS; HORSE; MALE; NONHUMAN; NUTRITIONAL STATUS; OSTEOARTHRITIS; OSTEOCHONDROSIS; OXIDATIVE STRESS; PRIORITY JOURNAL; PROTEIN ANALYSIS; PROTEIN EXPRESSION; PROTEOMICS; SYNOVIAL FLUID; TISSUE METABOLISM;

ANIMALS; BIOLOGICAL MARKERS; HORSE DISEASES; HORSES; OSTEOARTHRITIS; OSTEOCHONDROSIS; PROTEOME; SYNOVIAL FLUID;

ANIMALIA; EQUIDAE;

EID: 84863836130     PISSN: 18743919     EISSN: 18767737     Source Type: Journal    
DOI: 10.1016/j.jprot.2012.02.008     Document Type: Article

References (96)

1. Jeffcott L.B. Osteochondrosis in the horse-Searching for the key to pathogenesis. Equine Vet J 1991, 23:331-338.
2. Ferris D.J., Frisbie D.D., McIlwraith C.W., Kawcak C.E. Current joint therapy usage in equine practice: A survey of veterinarians 2009. Equine Vet J 2011, 43:530-535.
3. Ross M.W., Dyson S.J. Diagnosis and Management of Lameness in the Horse 2010, Saunders Company/Elsevier Inc., St. Louis.
4. McIlwraith C.W., Trotter G.T. Joint Disease of the Horse 1996, Saunders Company, Philadelphia.
5. van Weeren P.R. Etiology, diagnosis, and treatment of OC(D). Clin Tech Equine Pract 2006, 5:248-258.
6. Ekman S., Carlson C.S. The pathophysiology of osteochondrosis. Vet Clin North Am Small Anim Pract 1998, 28:17-32.
7. Jeffcott L.B., Henson M.D. Studies on growth cartilage in the horse and their application to aetiopathogenesis of dyschondroplasia (osteochondrosis). Vet J 1998, 156:177-192.
8. Ytrehus B., Carlson C.S., Ekman S. Etiology and Pathogenesis of Osteochondrosis. Vet Pathol 2007, 44:429-448.
9. Lecocq M., Girard C.A., Fogarty U., Beauchamp G., Richard H., Laverty S. Cartilage matrix changes in the developing epiphysis: Early events on the pathway to equine osteochondrosis?. Equine Vet J 2008, 40:442-454.
10. Frisbie D.D., Ray C.S., Ionescu M., Poole A.R., Chapman P.R., McIlwraith C.W. Measurement of synovial fluid and serum concentration of the 846 epitope of chondroitin sulfate and carboxy propeptides of type II procollagen for diagnosis of osteochondral fragmentation in horses. Am J Vet Res 1999, 60:306-309.
11. Serteyn D., Piquemal D., Vanderheyden L., Lejeune J.P., Verwilghen D., Sandersen C. Gene expression profiling from leukocytes of horses affected by osteochondrosis. J Orthop Res 2010, 28:965-970.
12. Olive J., D'Anjou M.A., Girard C., Laverty S., Theoret C. Fat-suppressed spoiled gradient-recalled imaging of equine metacarpophalangeal articular cartilage. Vet Radiol Ultrasound 2010, 51:107-115.
13. Hinz A., Fischer A.T. Comparison of the accuracy of radiography and ultrasonography for detection of articular lesions in horses. Vet Surg 2011, 40:881-885.
14. McIlwraith C.W. Use of synovial fluid and serum biomarkers in equine bone and joint disease: a review. Equine Vet J 2005, 37:473-482.
15. de Grauw J.C., van de Lest C.H.A., van Weeren P.R. Inflammatory mediators and cartilage biomarkers in synovial fluid after a single inflammatory insult: a longitudinal experimental study. Arthritis Res Ther 2009, 11:R35.
16. Garvican E.R., Vaughan-Thomas A., Innes J.F., Clegg P.D. Biomarkers of cartilage turnover. Part 1: markers of collagen degradation and synthesis. Vet J 2010, 185:36-42.
17. de Grauw J.C., Donabédian M., van de Lest C.H., Perona G., Robert C., Lepage O., et al. Assessment of synovial fluid biomarkers in healthy foals and in foals with tarsocrural osteochondrosis. Vet J 2011, 190:390-395.
18. Sutton S., Clutterbuck A., Harris P., Gent T., Freeman S., Foster N., et al. The contribution of the synovium, synovial derived inflammatory cytokines and neuropeptides to the pathogenesis of osteoarthritis. Vet J 2009, 179:10-24.
19. Misumi K., Vilim V., Clegg P.D., Thompson C.C., Carter S.D. Measurement of cartilage oligomeric matrix protein (COMP) in normal and diseased equine synovial fluids. Osteoarthritis Cartilage 2001, 9:119-127.
20. Arai K., Misumi K., Carter S.D., Shinbara S., Fujiki M., Sakamoto H. Analysis of cartilage oligomeric matrix protein (COMP) degradation and synthesis in equine joint disease. Equine Vet J 2005, 37:31-36.
21. Taylor S.E., Weaver M.P., Pitsillides A.A., Wheeler B.T., Wheeler-Jones C.P., Shaw D.J., et al. Cartilage oligomeric matrix protein and hyaluronan levels in synovial fluid from horses with osteoarthritis of the tarsometatarsal joint compared to a control population. Equine Vet J 2006, 38:502-507.
22. Ley C., Ekman S., Elmén A., Nilsson G., Eloranta M.L. Interleukin-6 and tumour necrosis factor in synovial fluid from horses with carpal joint pathology. J Vet Med A Physiol Pathol Clin Med 2007, 54:346-351.
23. Arai K., Tagami M., Hatazoe T., Nishimatsu E., Shimizu Y., Fujiki M., et al. Analysis of cartilage oligomeric matrix protein (COMP) in synovial fluid, serum and urine from 51 racehorses with carpal bone fracture. J Vet Med Sci 2008, 70:915-921.
24. Frisbie D.D., Al-Sobayil F., Billinghurst R.C., Kawcak C.E., McIlwraith C.W. Changes in synovial fluid and serum biomarkers with exercise and early osteoarthritis in horses. Osteoarthritis Cartilage 2008, 16:1196-1204.
25. Yamanokuchi K., Tagami M., Nishimatsu E., Shimizu Y., Hirose Y., Komatsu K., et al. Sandwich ELISA system for cartilage oligomeric matrix protein in equine synovial fluid and serum. Equine Vet J 2009, 4:41-46.
26. Kamm J.L., Nixon A.J., Witte T.H. Cytokine and catabolic enzyme expression in synovium, synovial fluid and articular cartilage of naturally osteoarthritic equine carpi. Equine Vet J 2010, 42:693-699.
27. Skiöldebrand E., Lorenzo P., Zunino L., Rucklidge G.J., Sandgren B., Carlsten J., et al. Concentration of collagen, aggrecan and cartilage oligomeric matrix protein (COMP) in synovial fluid from equine middle carpal joints. Equine Vet J 2001, 33:394-402.
28. Billinghurst R.C., Brama P.A., van Weeren P.R., Knowlton M.S., McIlwraith C.W. Evaluation of serum concentrations of biomarkers of skeletal metabolism and results of radiography as indicators of severity of osteochondrosis in foals. Am J Vet Res 2004, 65:143-150.
29. Donabédian M., Van Weeren P.R., Perona G., Fleurance G., Robert C., Léger S., et al. Early changes in biomarkers of skeletal metabolism and their association to the occurrence of osteochondrosis (OC) in the horse. Equine Vet J 2008, 40:253-259.
30. Tilleman K., Deforce D., Elewaut D. Rheumatology: a close encounter with proteomics. Rheumatology 2005, 44:1217-1226.
31. De Ceuninck F. The birth and infancy of proteomic analysis in osteoarthritis research. Curr Opin Mol Ther 2007, 9:263-269.
32. Kamphorst J.J., van der Heijden R., DeGroot J., Lafeber F.P., Reijmers T.H., van El B., et al. Profiling of endogenous peptides in human synovial fluid by NanoLC-MS: method validation and peptide identification. J Proteome Res 2007, 6:4388-4396.
33. Tilleman K., Deforce D. Proteomics in rheumatology. Expert Rev Proteomics 2008, 5:755-759.
34. Camafeita E., Lamas J.R., Calvo E., López J.A., Fernández-Gutiérrez B. Proteomics: New insights into rheumatic diseases. Proteomics Clin Appl 2009, 3:226-241.
35. Cano L., Arkfeld D.G. Targeted Synovial Fluid Proteomics for Biomarker Discovery in Rheumatoid Arthritis. Clin Proteomics 2009, 5:75-102.
36. Rosenkranz M.E., Wilson D.C., Marinov A.D., Decewicz A., Grof-Tisza P., Kirchner D., et al. Synovial fluid proteins differentiate between the subtypes of juvenile idiopathic arthritis. Arthritis Rheum 2010, 62:1813-1823.
37. Mateos J., Lourido L., Fernández-Puente P., Calamia V., Fernández-López C., Oreiro N., et al. Differential protein profiling of synovial fluid from rheumatoid arthritis and osteoarthritis patients using LC-MALDI TOF/TOF. J Proteomics 2012, 8.
38. Gobezie R., Kho A., Krastins B., Sarracino D.A., Thornhill T.S., Chase M., et al. High abundance synovial fluid proteome: distinct profiles in health and osteoarthritis. Arthritis Res Ther 2007, 9:R36.
39. Gibson D.S., Grant Jordan S.F., Scaife C., Brockbank S., Curry J., McAllister C., et al. Stratification and monitoring of juvenile idiopathic arthritis patients by synovial proteome analysis. J Proteome Res 2009, 8:5601-5609.
40. Gibson D.S., Blelock S.J., Curry J., Finnegan S., Healy A., Scaife C., et al. Comparative analysis of synovial fluid and plasma proteomes in juvenile arthritis - Proteomic patterns of joint inflammation in early stage disease. J Proteomics 2009, 7:656-676.
41. Blewis M.E., Nugent-Derfus G.E., Schmidt T.A., Schumacher B.L., Sah R.L. A model of synovial fluid lubricant composition in normal and injured joints. Eur Cell Mater 2007, 13:26-39.
42. Steel C.M. Equine synovial fluid analysis. Vet Clin North Am Equine Pract 2008, 24:437-454.
43. Catterall J.B., Stabler T.V., Flannery C.R., Kraus V.B. Changes in serum and synovial fluid biomarkers after acute injury. Arthritis Res Ther 2010, 12:R229.
44. Kokebie R., Aggarwa R., Lidder S., Hakimiyan A.A., Rueger D.C., Block J.A., et al. The role of synovial fluid markers of catabolism and anabolism in osteoarthritis, rheumatoid arthritis and asymptomatic organ donors. Arthritis Res Ther 2011, 13:R50.
45. Honsawek S., Chayanupatkul M. Correlation of plasma and synovial fluid adiponectin with knee osteoarthritis severity. Arch Med Res 2010, 41:593-598.
46. Frisbie D.D., Kawcak C.E., Werpy N.M., Park R.D., McIlwraith C.W. Clinical, biochemical, and histologic effects of intraarticular administration of autologous conditioned serum in horses with experimentally induced osteoarthritis. Am J Vet Res 2007, 68:290-296.
47. Fox B.A., Stephens M.M. Treatment of knee osteoarthritis with Orthokine®-derived autologous conditioned serum. Expert Rev Clin Immunol 2010, 6:335-345.
48. Hraha T.H., Doremus K.M., McIlwraith C.W., Frisbie D.D. Autologous conditioned serum: the comparative cytokine profiles of two commercial methods (IRAP and IRAP II) using equine blood. Equine Vet J 2011, 43:516-521.
49. Malemud C.J. Anticytokine therapy for osteoarthritis: evidence to date. Drugs Aging 2010, 27:95-115.
50. Meijer H., Reinecke J., Becker C., Tholen G., Wehling P. The production of anti-inflammatory cytokines in whole blood by physico-chemical induction. Inflamm Res 2003, 52:404-407.
51. Wehling P., Moser C., Frisbie D., McIlwraith C.W., Kawcak C., Krauspe R., et al. Autologous Conditioned Serum in the Treatment of Orthopedic Diseases: The Orthokine® Therapy. BioDrugs 2007, 21:323-332.
52. Aigner T., Cook J.L., Gerwin N., Glasson S.S., Laverty S., Little C.B., et al. Histopathology atlas of animal model systems - overview of guiding principles. Osteoarthritis Cartilage 2010, 18(Suppl. 3):S2-S6.
53. Talamo F., D'Ambrosio C., Arena S., Del Vecchio P., Ledda L., Zehender G., et al. Proteins from bovine tissues and biological fluids: defining a reference electrophoresis map for liver, kidney, muscle, plasma and red blood cells. Proteomics 2003, 3:440-460.
54. Scippa G.S., Rocco M., Ialicicco M., Trupiano D., Viscosi V., Di Michele M., et al. The proteome of lentil (Lens culinaris Medik.) seeds: discriminating between landraces. Electrophoresis 2010, 31:497-506.
55. Perkins D.N., Pappin D.J., Creasy D.M., Cottrell J.S. Probability-based protein identification by searching sequence databases using mass spectrometry data. Electrophoresis 1999, 20:3551-3567.
56. Lin E.A., Liu C.J. The role of ADAMTSs in arthritis. Protein Cell 2010, 33-47.
57. Cáceres L.C., Bonacci G.R., Sánchez M.C., Chiabrando G.A. Activated α(2) macroglobulin induces matrix metalloproteinase 9 expression by low-density lipoprotein receptor-related protein 1 through MAPK-ERK1/2 and NF-κB activation in macrophage-derived cell lines. J Cell Biochem 2010, 15:607-617.
58. Wu S.M., Pizzo S.V. α2-Macroglobulin from Rheumatoid Arthritis Synovial Fluid: Functional Analysis Defines a Role for Oxidation in Inflammation. Arch Biochem Biophys 2001, 391:119-126.
59. Hultén C., Grönlund U., Hirvonen J., Tulamo R.M., Suominen M.M., Marhaug G., et al. Dynamics in serum of the inflammatory markers serum amyloid A (SAA), haptoglobin, fibrinogen and alpha2-globulins during induced noninfectious arthritis in the horse. Equine Vet J 2002, 34:699-704.
60. Pejovic M., Stankovic A., Mitrovic D.R. Determination of the apparent synovial permeability in the knee joint of patients suffering from osteoarthritis and rheumatoid arthritis. Br J Rheumatol 1995, 34:520-524.
61. Lauer M.E., Fulop C., Mukhopadhyay D., Comhair S., Erzurum S.C., Hascall V.C. Airway Smooth Muscle Cells Synthesize Hyaluronan Cable Structures Independent of Inter-a-inhibitor Heavy Chain Attachment. J Biol Chem 2009, 284:5313-5323.
62. Trumble T.N., Trotter G.W., Oxford J.R., McIlwraith C.W., Cammarata S., Goodnight J.L., et al. Synovial fluid gelatinase concentrations and matrix metalloproteinase and cytokine expression in naturally occurring joint disease in horses. Am J Vet Res 2001, 62:1467-1477.
63. Kuroki K., Cook J.L., Stoker A.M., Turnquist S.E., Kreeger J.M., Tomlinson J.L. Characterizing osteochondrosis in the dog: potential roles for matrix metalloproteinases and mechanical load in pathogenesis and disease progression. Osteoarthritis Cartilage 2005, 13:225-234.
64. Ryan M.H., Petrone D., Nemeth J.F., Barnathan E., Bjorck L., Jordan R.E. Proteolysis of purified IgGs by human and bacterial enzymes in vitro and the detection of specific proteolytic fragments of endogenous IgG in rheumatoid synovial fluid. Mol Immunol 2008, 45:1837-1846.
65. Kratz E.M., Borysewicz K., Katnik-Prastowska I. Terminal monosaccharide screening of synovial immunoglobulins G and A for the early detection of rheumatoid arthritis. Rheumatol Int 2010, 30:1285-1292.
66. John T., Stahel P.F., Morgan S.J., Schulze-Tanzil G. Impact of the complement cascade on posttraumatic cartilage inflammation and degradation. Histol Histopathol 2007, 22:781-790.
67. Sofat N. Analysing the role of endogenous matrix molecules in the development of osteoarthritis. Review. Int J Exp Pathol 2009, 90:463-479.
68. Choi G., Schultz M.J., Levi M., van der Poll T. The relationship between inflammation and the coagulation system. Swiss Med Wkly 2006, 4:139-144.
69. Bradley K., North J., Saunders D., Schwaeble W., Jeziorska M., Woolley D.E., et al. Synthesis of classical pathway complement components by chondrocytes. Immunology 1996, 88:648-856.
70. Neumann E., Barnum S.R., Tarner I.H., Echols J., Fleck M., Judex M., et al. Local production of complement proteins in rheumatoid arthritis synovium. Arthritis Rheum 2002, 46:934-945.
71. Rosenthal A.K., Gohr C.M., Ninomiya J., Wakim B.T. Proteomic analysis of articular cartilage vesicles from normal and osteoarthritic cartilage. Arthritis Rheum 2011, 63:401-411.
72. Happonen K.E., Saxne T., Aspberg A., Mörgelin M., Heinegård D., Blom A.M. Regulation of complement by cartilage oligomeric matrix protein allows for a novel molecular diagnostic principle in rheumatoid arthritis. Arthritis Rheum 2010, 62:3574-3583.
73. Andrades J.A., Nimni M.E., Becerra J., Eisenstein R., Davis M., Sorgente N. Complement proteins are present in developing endochondral bone and may mediate cartilage cell death and vascularization. Exp Cell Res 1996, 15:208-213.
74. Jones H.W., Bailey R., Zhang Z., Dunne K.A., Blake D.R., Cox N.L., et al. Inactivation of antithrombin III in synovial fluid from patients with rheumatoid arthritis. Ann Rheum Dis 1998, 57:162-165.
75. Chang X., Yamada R., Yamamoto K. Inhibition of antithrombin by hyaluronic acid may be involved in the pathogenesis of rheumatoid arthritis. Arthritis Res Ther 2005, 7:268-273.
76. Flick M.J., LaJeunesse C.M., Talmage K.E., Witte D.P., Palumbo J.S., Pinkerton M.D., et al. Fibrin(ogen) exacerbates inflammatory joint disease through a mechanism linked to the integrin alphaMbeta2 binding motif. J Clin Invest 2007, 117:3224-3235.
77. Craven S., Dewar L., Yang X., Ginsberg J., Ofosu F. Altered regulation of in-vivo coagulation in orthopedic patients prior to knee or hip replacement surgery. Blood Coagul Fibrinolysis 2007, 18:219-225.
78. Ashraf S., Walsh D.A. Angiogenesis in osteoarthritis. Curr Opin Rheumatol 2008, 20:573-580.
79. Busso N., Dudler J., Salvi R., Péclat V., Lenain V., Marcovina S., et al. Plasma apolipoprotein(a) co-deposits with fibrin in inflammatory arthritic joints. Am J Pathol 2001, 159:1445-1453.
80. Sánchez-Enríquez S., Torres-Carrillo N.M., Vázquez-Del Mercado M., Salgado-Goytia L.R., Rangel-Villalobos H., Muñoz-Valle J.F. Increase levels of apo-A1 and apo B are associated in knee osteoarthritis: lack of association with VEGF-460 T/C and +405 C/G polymorphisms. Rheumatol Int 2008, 29:63-68.
81. Oliviero F., Sfriso P., Baldo G., Dayer J.M., Giunco S., Scanu A., et al. Apolipoprotein A-I and cholesterol in synovial fluid of patients with rheumatoid arthritis, psoriatic arthritis and osteoarthritis. Clin Exp Rheumatol 2009, 27:79-83.
82. Masuko K., Murata M., Suematsu N., Okamoto K., Yudoh K., Nakamura H., et al. A metabolic aspect of osteoarthritis: lipid as a possible contributor to the pathogenesis of cartilage degradation. Clin Exp Rheumatol 2009, 27:347-753.
83. Vieth R., Vitamin D. Toxicity, policy, and science. J Bone Miner Res 2007, 22:S264-S268.
84. Satoh T., Hosokawa M. Structure, function and regulation of carboxylesterases. Chem Biol Interact 2006, 162:195-211.
85. Jerkovic L., Voegele A.F., Chwatal S., Kronenberg F., Radcliffe C.M., Wormald M.R., et al. Afamin is a novel human vitamin e-binding glycoprotein characterization and in vitro expression. J Proteome Res 2005, 4:889-899.
86. Henrotin Y.E., Bruckner P., Pujol P.J. The role of reactive oxygen species in homeostasis and degradation of cartilage. Osteoarthritis Cartilage 2003, 11:747-755.
87. Yazar M., Sarban S., Kocyigit A., Isikan U.E. Synovial fluid and plasma selenium, copper, zinc, and iron concentrations in patients with rheumatoid arthritis and osteoarthritis. Biol Trace Elem Res 2005, 106:123-132.
88. Regan E.A., Bowler R.P., Crapo J.D. Joint fluid antioxidants are decreased in osteoarthritic joints compared to joints with macroscopically intact cartilage and subacute injury. Osteoarthritis Cartilage 2008, 16:515-521.
89. Sutipornpalangkul W., Morales N.P., Charoencholvanich K., Harnroongroj T. Lipid peroxidation, glutathione, vitamin E, and antioxidant enzymes in synovial fluid from patients with osteoarthritis. Int J Rheum Dis 2009, 12:324-328.
90. Kagan H.M., Li W. Lysyl oxidase: properties, specificity, and biological roles inside and outside of the cell. J Cell Biochem 2003, 8:660-672.
91. Badadani M., Shetty K.T., Babu S.V.S. Metabolic status of magnesium and ceruloplasmin in Handigodu Joint Disease: a variety of spondylo epi (meta) physeal dysplasia. Clin Chim Acta 2007, 395:170-171.
92. van Weeren P.R., Knaap J., Firth E.C. Influence of liver copper status of mare and newborn foal on the development of osteochondrotic lesions. Equine Vet J 2003, 35:67-71.
93. Kisker O., Onizuka S., Becker C.M., Fannon M., Flynn E., D'Amato R., et al. Vitamin D binding protein-macrophage activating factor (DBP-maf) inhibits angiogenesis and fumor growth in mice. Neoplasia 2003, 5:32-40.
94. Schneider G.B., Grecco K.J., Safadi F.F., Popoff S.N. The anabolic effects of vitamin D-binding protein-macrophage activating factor (DBP-MAF) and a novel small peptide on bone. Crit Rev Eukaryot Gene Expr 2003, 13:277-284.
95. Lee W.M., Galbraith R.M. The extracellular actin-scavenger system and actin toxicity. N Engl J Med 1992, 326:1335-1341.
96. Blain E.J. Involvement of the cytoskeletal elements in articular cartilage homeostasis and pathology. Int J Exp Pathol 2009, 90:1-15.